To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients

NCT06866509 · clinicaltrials.gov ↗

COMPLETED

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Litorvazet Tablet 10/10mg
DRUG: Litorvazet Tablet10/20mg
DRUG: Litorvazet Tablet 10/40mg

Sponsor

Daewoong Pharmaceutical Co. LTD.